Progyny, Inc. currently boasts a market capitalization of $3.57 billion and a P/E ratio of 76.29. Progyyn has 29.6% sales growth and 12.63% return on equity.

Bank of New York Mellon Corp Reduces Stake in Progyny, Inc. as company outperforms expectations - best stocks. Progyny operates on NASDAQ under the ticker symbol PGNY and opened trading at $37.38 on August 28th, 2023. Currently boasting a market capitalization of $3.57 billion and a P/E ratio of 76.29, Progygyny presents itself as an attractive investment option. Progyny - PGNY - Stock Price Today - Zacks Is It Time to Buy PGNY? Shares are up today. progyny, inc. (nasdaq:pgny) shares sold by exoduspoint capital management lp - defense world. Bank of America boosted their target price on shares of Progyny from $48.00 to $50.00 in a research note on Tuesday, May 9th. Bank of A&M boosted the target price of shares of the benefits management company. Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. The company has 29.6% sales growth and 12.63% return on equity. Progyny (PGNY) is one such stock that our proprietary system currently recommends. While the historical EPS growth rate for ProgyNY is 75.4%, investors should actually focus on the projected growth. Right now, Progyyn has an S/TA ratio of 1.61, which means that the company gets $1.61 for each dollar in assets.